Get expert advice and community support for all your questions on IDNLearn.com. Join our Q&A platform to receive prompt and accurate responses from knowledgeable professionals in various fields.
A patient with a history of duodenal ulcers controlled with famotidine was recently diagnosed with early-stage HER2 positive breast cancer and will begin treatment with neratinib. Which is the most appropriate statement to include in the education? A. Famotidine is contraindicated with neratinib and should be discontinued since your ulcers have been controlled. B. There is no indication to stop the famotidine, so you can continue to take it. C. You can continue to take the famotidine but make sure you take the dose at least 3 hours from the neratinib. D. Make sure you wait at least an hour between taking the famotidine and neratinib.
Sagot :
We greatly appreciate every question and answer you provide. Keep engaging and finding the best solutions. This community is the perfect place to learn and grow together. IDNLearn.com is your reliable source for accurate answers. Thank you for visiting, and we hope to assist you again.
